SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a focal point for intense community debate, with many traders holding polarized views on whether the asset represents a long-term opportunity or a declining trend. While some holders emphasize their conviction and anticipation of a potential market rally, a significant portion of the conversation is dominated by frustration over stagnant performance and skepticism regarding the project's long-term utility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is capturing investor attention as its multi-layered autonomous driving strategy gains traction, highlighted by a significant partnership with Lenovo to scale global deployment of autonomous vehicles and successful commercial robotaxi launches in markets like Dubai. Community sentiment is increasingly bullish, focusing on the company's competitive edge in L4-rated technology and the recent surge in institutional interest that suggests a potential shift toward stronger fundamental valuation.

Chip

CHIP is gaining momentum as investors bet on USD.AI's role in financing physical AI infrastructure through GPU-backed lending. The community is actively debating the project's long-term utility against volatility and supply concerns, with many focusing on its potential as a governance layer for the growing AI compute market.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors debate the geopolitical ramifications of a new U.S.-Iran memorandum of understanding, alongside intense community discourse regarding the administration's recent foreign policy decisions. Participants are actively engaging in heated political debates, with many users fixating on the broader market impact of these developments and ongoing controversies surrounding the company's valuation.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending due to a co-development partnership with AI startup Midjourney, which highlights the company's semiconductor-based ultrasound-on-chip technology. Community members are actively debating the long-term potential of this strategic deal, with some long-term holders expressing high conviction while others caution against volatility and historical patterns of share offerings.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as community discussions focus on strong quarterly results and reaffirmed full-year guidance, which successfully navigated geopolitical headwinds and Middle East disruptions. Investors are particularly optimistic about the company's expanding nuclear footprint, specifically the SMR commercial contracts in Europe, alongside robust engine demand across civil and defense sectors.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

The IBIT ETF is trending due to institutional options activity and intense community debate surrounding potential legislative catalysts like the Clarity Act. Traders are closely monitoring this price action as participants weigh speculative upside against broader market volatility and institutional distribution patterns.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as investors digest record-breaking revenue growth driven by sustained AI infrastructure demand, despite ongoing market caution regarding its reliance on advanced semiconductor manufacturing capacity. The community is actively debating the stock's long-term dominance as the essential foundry backbone for AI, weighed against persistent geopolitical risks and intense competition in next-generation chip packaging.

Anthropic

Anthropic is trending as it faces intense U.S. government scrutiny and forced restrictions on its most advanced AI models, Fable 5 and Mythos 5, due to national security concerns. The community is actively debating the company's IPO prospects, its competitive positioning against rivals like OpenAI and SpaceX, and the broader implications of rising AI regulation.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is attracting attention as it navigates a transition away from Humira, with investors closely watching its immunology growth and recent strategic M&A activity in the oncology and obesity spaces. Meanwhile, the community is actively debating the potential for acquisition-driven catalysts in the biotech sector, particularly centering on discussions around competitive drug readouts and the strategic value of late-stage pipeline assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Caris Life Sciences Announces Dual Listing on NYSE Texas

Caris Life Sciences Announces Dual Listing on NYSE Texas Caris Life Sciences Announces Dual Listing on NYSE Texas PR Newswire IRVING, Texas, June 16, 2026 IRVING, Texas, June 16, 2026 /PRNewswire/ -- Caris Life Sciences (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and...

Caris Life Sciences Authorized Buy Back Up To $100 Mln

(RTTNews) - Caris Life Sciences (CAI), an AI TechBio company, Monday announced that it has been authorized to repurchase up to $100 million of the company's outstanding common stock...

Caris Life Sciences Announces Share Repurchase Program

Caris Life Sciences Announces Share Repurchase Program Caris Life Sciences Announces Share Repurchase Program PR Newswire IRVING, Texas, June 8, 2026 IRVING, Texas, June 8, 2026 /PRNewswire/ -- Caris Life Sciences (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio...

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing PR Newswire IRVING...

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with...

Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels

Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels Caris Life...

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure BloodBased Testing Authorization

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure BloodBased Testing Authorization Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure BloodBased Testing Authorization PR Newswire IRVING, Texas, May 8, 2026...

Caris Life Sciences Q1 Loss Narrows

(RTTNews) - Caris Life Sciences (CAI) on Thursday reported first-quarter results with revenue rising sharply from last year while losses narrowed, driven by strong growth in molecular profiling services...

Caris Life Sciences Reports First Quarter 2026 Financial Results

Caris Life Sciences Reports First Quarter 2026 Financial Results Caris Life Sciences Reports First Quarter 2026 Financial Results PR Newswire IRVING, Texas, May 7, 2026 Revenue growth of 79% driven...

UBS Group AG Raises Stock Position in Caris Life Sciences, Inc. $CAI

UBS Group AG lifted its stake in shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 825.9% during the fourth quarter, according to the company in its most recent Form 13F filing with...

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

Caris Life Sciences Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

CAICaris Life Sciences Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CAI News